• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

槲皮素对肺炎链球菌的抗菌作用。

Antimicrobial effect of quercetin against Streptococcus pneumoniae.

机构信息

Virology Laboratory, Graduate Program in Microbial Biology, Brazil.

Laboratory of Environmental Microbiology, Graduate Program in Microbial Biology, Brazil.

出版信息

Microb Pathog. 2023 Jul;180:106119. doi: 10.1016/j.micpath.2023.106119. Epub 2023 Apr 23.

DOI:10.1016/j.micpath.2023.106119
PMID:37098385
Abstract

Streptococcus pneumoniae is a bacterium that causes serious infections, including pneumonia. The limited range of available vaccines and the rise of antibiotic-resistant bacteria mean that new treatments are needed. This study looked at the potential of quercetin as an antimicrobial agent against S. pneumoniae in both isolation and in biofilms. The researchers used microdilution tests, checkerboard assays, and death curve assays, as well as in silico and in vitro cytotoxicity evaluations. They found that quercetin at a concentration of 125.0 μg/mL had both inhibitory and bactericidal effects against S. pneumoniae, and these effects were increased when quercetin was combined with ampicillin. Quercetin also reduced the growth of pneumococcal biofilms. In addition, quercetin (absence or in combination with ampicillin) reduced the death time of Tenebrio molitor larvae compared to the infection control. The study also demonstrated that quercetin had low toxicity in both in silico and in vivo assays, suggesting that it could be a promising treatment for infections caused by S. pneumoniae.

摘要

肺炎链球菌是一种可导致严重感染的细菌,包括肺炎。可用疫苗种类有限,且抗生素耐药菌不断增加,这意味着需要新的治疗方法。本研究着眼于槲皮素作为一种抗肺炎链球菌的抗菌剂的潜力,包括在分离状态和生物膜状态下的效果。研究人员使用微量稀释试验、棋盘试验、死亡曲线试验以及体内外细胞毒性评估。他们发现,槲皮素在浓度为 125.0μg/mL 时对肺炎链球菌具有抑制和杀菌作用,当与氨苄西林联合使用时,这些作用会增强。槲皮素还能抑制肺炎链球菌生物膜的生长。此外,与感染对照组相比,槲皮素(单独或与氨苄西林联合)能减少黄粉虫幼虫的死亡时间。该研究还表明,槲皮素在体内和体外试验中均具有低毒性,这表明它可能是治疗肺炎链球菌感染的一种有前途的方法。

相似文献

1
Antimicrobial effect of quercetin against Streptococcus pneumoniae.槲皮素对肺炎链球菌的抗菌作用。
Microb Pathog. 2023 Jul;180:106119. doi: 10.1016/j.micpath.2023.106119. Epub 2023 Apr 23.
2
Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae.槲皮素配合物对肺炎链球菌的治疗潜力活性。
Sci Rep. 2024 Jun 5;14(1):12876. doi: 10.1038/s41598-024-62782-w.
3
Combination of Cefditoren and -acetyl-l-Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms.头孢地尼和乙酰半胱氨酸联合使用对多药耐药肺炎链球菌生物膜显示协同作用。
Microbiol Spectr. 2022 Dec 21;10(6):e0341522. doi: 10.1128/spectrum.03415-22. Epub 2022 Nov 29.
4
Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996.肺炎链球菌不断演变的临床问题:1993年至1996年期间在伊利诺伊州芝加哥市,其对抗菌药物的耐药性增加,以及传统奥普托欣鉴定方法失效。
Diagn Microbiol Infect Dis. 1997 Dec;29(4):209-14. doi: 10.1016/s0732-8893(97)00141-7.
5
Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection.槲皮素是肺炎球菌溶血素的抑制剂,可保护小鼠免受肺炎链球菌感染。
Microb Pathog. 2020 Mar;140:103934. doi: 10.1016/j.micpath.2019.103934. Epub 2019 Dec 17.
6
The prevalence and antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients at Jikei University Hospitals after the implementation of the pneumococcal vaccination program in Japan.日本实施肺炎球菌疫苗接种计划后,从东京慈惠会医科大学医院患者中分离出的肺炎链球菌的流行情况及抗菌药物敏感性
J Infect Chemother. 2020 Jul;26(7):769-774. doi: 10.1016/j.jiac.2020.04.018. Epub 2020 May 14.
7
Amoxicillin-resistant can be resensitized by targeting the mevalonate pathway as indicated by sCRilecs-seq.阿莫西林耐药可以通过靶向甲羟戊酸途径重新敏感化,如 sCRilecs-seq 所示。
Elife. 2022 Jun 24;11:e75607. doi: 10.7554/eLife.75607.
8
Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.2011 年至 2016 年中国 17 个城市肺炎链球菌分离株的血清型分布和抗生素耐药性。
BMC Infect Dis. 2017 Dec 29;17(1):804. doi: 10.1186/s12879-017-2880-0.
9
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.美国分离出的肺炎链球菌的抗菌耐药性趋势:来自美国PROTEKT研究1-4年的最新情况。
Ann Clin Microbiol Antimicrob. 2008 Jan 11;7:1. doi: 10.1186/1476-0711-7-1.
10
The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.AmiACDEF 寡肽转运蛋白介导 2 型肺炎链球菌 D39 对趋化因子 CXCL10 和其他抗菌肽杀伤作用的耐药性。
J Bacteriol. 2018 May 9;200(11). doi: 10.1128/JB.00745-17. Print 2018 Jun 1.

引用本文的文献

1
Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae.槲皮素配合物对肺炎链球菌的治疗潜力活性。
Sci Rep. 2024 Jun 5;14(1):12876. doi: 10.1038/s41598-024-62782-w.